NCT05704049 2025-12-29
IZALCO
Sanofi
Phase 2 Active not recruiting
Clinical Trials
5 trialsNCT04126200 2025-11-06
DREAMM5
GlaxoSmithKline
Phase 2 Active not recruiting
NCT03860844 2025-09-09
ISAKIDS
Sanofi
Phase 2 Terminated
NCT05669989 2025-01-23
International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab
Sanofi
Phase 2 Active not recruiting
NCT02999633 2022-03-21
ISLAY
Sanofi
Phase 2 Terminated